NO168773C - Fremgangsmaate for spaltning av racemiske spiro-hydantoiner - Google Patents

Fremgangsmaate for spaltning av racemiske spiro-hydantoiner

Info

Publication number
NO168773C
NO168773C NO893053A NO893053A NO168773C NO 168773 C NO168773 C NO 168773C NO 893053 A NO893053 A NO 893053A NO 893053 A NO893053 A NO 893053A NO 168773 C NO168773 C NO 168773C
Authority
NO
Norway
Prior art keywords
spiro
ureido
compound
racemic
dione
Prior art date
Application number
NO893053A
Other languages
English (en)
Norwegian (no)
Other versions
NO893053L (no
NO168773B (no
NO893053D0 (no
Inventor
Marcus Brackeen
Jr Harry Ralph Howard
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO893053D0 publication Critical patent/NO893053D0/no
Publication of NO893053L publication Critical patent/NO893053L/no
Publication of NO168773B publication Critical patent/NO168773B/no
Publication of NO168773C publication Critical patent/NO168773C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
NO893053A 1988-07-27 1989-07-26 Fremgangsmaate for spaltning av racemiske spiro-hydantoiner NO168773C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/224,966 US4952694A (en) 1988-07-27 1988-07-27 Novel resolution process for racemic spiro-hydantoins

Publications (4)

Publication Number Publication Date
NO893053D0 NO893053D0 (no) 1989-07-26
NO893053L NO893053L (no) 1990-01-29
NO168773B NO168773B (no) 1991-12-23
NO168773C true NO168773C (no) 1992-04-01

Family

ID=22842974

Family Applications (1)

Application Number Title Priority Date Filing Date
NO893053A NO168773C (no) 1988-07-27 1989-07-26 Fremgangsmaate for spaltning av racemiske spiro-hydantoiner

Country Status (24)

Country Link
US (1) US4952694A (de)
EP (1) EP0352959B1 (de)
JP (1) JPH0625152B2 (de)
KR (1) KR910002839B1 (de)
CN (1) CN1023645C (de)
AT (1) ATE93859T1 (de)
DD (1) DD284020A5 (de)
DE (1) DE68908812T2 (de)
DK (1) DK169033B1 (de)
EG (1) EG18934A (de)
ES (1) ES2058537T3 (de)
FI (1) FI893576A7 (de)
HU (1) HU204527B (de)
IE (1) IE892420L (de)
IL (1) IL91055A0 (de)
MX (1) MX173143B (de)
MY (1) MY104136A (de)
NO (1) NO168773C (de)
NZ (1) NZ230091A (de)
PL (1) PL161181B1 (de)
PT (1) PT91273A (de)
RU (1) RU1777599C (de)
YU (1) YU47209B (de)
ZA (1) ZA895680B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5151544A (en) * 1990-05-25 1992-09-29 Alcon Laboratories, Inc. Intermediates in the preparation of chiral spirofluorenehydantoins
US5206367A (en) * 1992-02-18 1993-04-27 Pfizer Inc. Preparation of optically active spiro-hydantoins
US5811605A (en) * 1997-02-19 1998-09-22 Ppg Industries, Inc. Preparation of 1,2,3,3-tetrachloropropene
US8258313B2 (en) * 2007-07-19 2012-09-04 Tokuyama Corporation Compound having hydantoin ring and method of producing the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4117230A (en) * 1976-10-18 1978-09-26 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines
EP0109231B1 (de) * 1982-11-10 1986-10-22 Pfizer Inc. Sorbinil durch optische Aufspaltung mit Aminopinanderivaten
EP0172719B1 (de) * 1984-08-20 1988-09-21 Pfizer Inc. Verfahren zur Herstellung asymmetrischer Hydantoine
WO1986002647A1 (en) * 1984-10-30 1986-05-09 Pfizer Inc. Spiro-heteroazolones for treatment of diabetes complications

Also Published As

Publication number Publication date
CN1040199A (zh) 1990-03-07
FI893576L (fi) 1990-01-28
MY104136A (en) 1994-02-28
AU603301B2 (en) 1990-11-08
JPH0625152B2 (ja) 1994-04-06
KR910002839B1 (ko) 1991-05-06
MX16955A (es) 1993-06-01
AU3898889A (en) 1990-02-01
DK367889D0 (da) 1989-07-26
ZA895680B (en) 1991-03-27
IE892420L (en) 1990-01-27
YU149189A (en) 1991-02-28
NZ230091A (en) 1991-01-29
NO893053L (no) 1990-01-29
HUT56369A (en) 1991-08-28
PT91273A (pt) 1990-02-08
ATE93859T1 (de) 1993-09-15
FI893576A0 (fi) 1989-07-26
CN1023645C (zh) 1994-02-02
PL161181B1 (pl) 1993-05-31
DD284020A5 (de) 1990-10-31
EP0352959B1 (de) 1993-09-01
DK169033B1 (da) 1994-08-01
EP0352959A1 (de) 1990-01-31
ES2058537T3 (es) 1994-11-01
NO168773B (no) 1991-12-23
MX173143B (es) 1994-02-02
FI893576A7 (fi) 1990-01-28
HU204527B (en) 1992-01-28
DE68908812D1 (de) 1993-10-07
IL91055A0 (en) 1990-02-09
DK367889A (da) 1990-01-29
EG18934A (en) 1994-03-30
RU1777599C (ru) 1992-11-23
KR910002862A (ko) 1991-02-26
NO893053D0 (no) 1989-07-26
DE68908812T2 (de) 1993-12-09
YU47209B (sh) 1995-01-31
JPH0288576A (ja) 1990-03-28
US4952694A (en) 1990-08-28

Similar Documents

Publication Publication Date Title
ATE224896T1 (de) Verfahren zur herstellung von enantiomerisch reinen imidazol-verbindungen
HUT52162A (en) New process for producing optically active
NO168773C (no) Fremgangsmaate for spaltning av racemiske spiro-hydantoiner
Shimada et al. Diastereoselective ring-opening aldol-type reaction of 2, 2-dialkoxycyclopropanecarboxylic esters with carbonyl compounds. 2. Synthesis of cis-2, 3-substituted-γ-lactones
AU556793B2 (en) Sorbinil and methylsorbinil
AU4070893A (en) Method for producing s-timolol
DE3572965D1 (en) Process for the production of optically active quinone derivatives
EP0046679A3 (de) Totale Synthese von 1RS,4SR,5RS-4-(4,8-dimethyl-5-hydroxy-7-nonen-1-yl)-4-methyl-3,8-dioxabicyclo (3.2.1)octan-1-essigsäure
PL245203A1 (en) Process for manufacturing racemic trinuclear heterocyclic compounds containing spiro bonds
JPS6431775A (en) Production of (r)-(+)-gamma-butyrolactone-gamma-3-propionic acid